Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Breeman

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine|July 1, 1996
Iodine-131 labelled octreotide: not an option for somatostatin receptor therapyW H Bakker, W A Breeman, M E van der Pluijm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1996
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivoM de Jong, E J Rolleman, B F Bernard, et al.
The British Journal of Surgery|January 3, 2001
Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumoursG D Slooter, A Mearadji, W A Breeman, et al.
Nuclear Medicine and Biology|June 10, 1998
99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivoB F Bernard, E P Krenning, W A Breeman, et al.
European Journal of Nuclear Medicine|October 1, 1996
Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell linesM de Jong, B F Bernard, W A Breeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptakeB F Bernard, E P Krenning, W A Breeman, et al.
European Journal of Nuclear Medicine|October 5, 2001
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectivesW A Breeman, M de Jong, D J Kwekkeboom, et al.
Digestion|January 1, 1996
Somatostatin receptor: scintigraphy and radionuclide therapyE P Krenning, P P Kooij, S Pauwels, et al.
European Journal of Nuclear Medicine|March 1, 1997
Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancerH J Bonjer, H A Bruining, H A Pols, et al.
International Journal of Cancer|May 4, 1999
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapyW A Breeman, L J Hofland, M de Jong, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine|July 1, 1996
Iodine-131 labelled octreotide: not an option for somatostatin receptor therapyW H Bakker, W A Breeman, M E van der Pluijm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1996
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivoM de Jong, E J Rolleman, B F Bernard, et al.
The British Journal of Surgery|January 3, 2001
Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumoursG D Slooter, A Mearadji, W A Breeman, et al.
Nuclear Medicine and Biology|June 10, 1998
99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivoB F Bernard, E P Krenning, W A Breeman, et al.
European Journal of Nuclear Medicine|October 1, 1996
Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell linesM de Jong, B F Bernard, W A Breeman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 1998
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptakeB F Bernard, E P Krenning, W A Breeman, et al.
European Journal of Nuclear Medicine|October 5, 2001
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectivesW A Breeman, M de Jong, D J Kwekkeboom, et al.
Digestion|January 1, 1996
Somatostatin receptor: scintigraphy and radionuclide therapyE P Krenning, P P Kooij, S Pauwels, et al.
European Journal of Nuclear Medicine|March 1, 1997
Intraoperative nuclear guidance in benign hyperparathyroidism and parathyroid cancerH J Bonjer, H A Bruining, H A Pols, et al.
International Journal of Cancer|May 4, 1999
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapyW A Breeman, L J Hofland, M de Jong, et al.
Pageof 6